Interestingly, at presentation GSD IV patients with LT had more severe liver damage and liver function parameters, but nevertheless showed a significant improvement before LT was performed (median ALT improved from 244 to 134 U/L). The gene discussed is GPT; the disease is glycogen storage disease due to glycogen branching enzyme deficiency.